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ABSTRACT
IiB kinase a (IKKa) is part of the cytoplasmic IKK
complex regulating nuclear factor-{kappa}B (NF-iB)
release and translocation into the nucleus in
response to pro-inflammatory signals. IKKa can
also be recruited directly to the promoter of
NF-iB-dependent genes by NF-iB where it phos-
phorylates histone H3 at serine 10, triggering recruit-
ment of the bromodomain-containing protein 4 and
the positive transcription elongation factor b. Herein,
we report that IKKa travels with the elongating form
of ribonucleic acid polymerase II together with het-
erochromatin protein 1 gamma (HP1c) at NF-iB-
dependent genes in activated macrophages. IKKa
binds to and phosphorylates HP1c, which in turn
controls IKKa binding to chromatin and phosphoryl-
ation of the histone variant H3.3 at serine 31 within
transcribing regions. Downstream of transcription
end sites, IKKa accumulates with its inhibitor the
CUE-domain containing protein 2, suggesting a link
between IKKa inactivation and transcription
termination.
INTRODUCTION
The nuclear factor-{kappa}B (NF-kB) family of transcrip-
tion factors is involved in a variety of physiological and
pathological processes such as development, immunity,
tissue homeostasis and inﬂammation with abundant epi-
demiological data showing a strong correlation between
inﬂammation and cancer incidence (1). In unstimulated
cells, NF-kB is sequestered in the cytoplasm bound to a
family of proteins known as IkB. On stimulation, IkB is
phosphorylated by the IkB kinase (IKK) complex,
allowing NF-kB to translocate into the nucleus and to
stimulate transcription of its target genes. The IKK
complex includes two catalytic subunits, IKKa, IKKb
and a regulatory subunit IKKg/Nemo. In the nucleus,
NF-kB interacts with several chromatin modiﬁers
including the histone H3K4 methyltransferase Set7/9 (2),
the lysine acetyltransferase CBP/p300 (3) and IKKa for
which speciﬁc chromatin modiﬁer activity has been
described (4). Some NF-kB-dependent genes, which
function as rapidly induced primary response genes,
produce a low level of non-processed primary transcripts
in macrophages even before activation (5). On induction,
these NF-kB-dependent genes recruit positive transcrip-
tion elongation factor b (p-TEFb), which controls both
the release of the promoter-proximal paused ribonucleic
acid (RNA) polymerase II (RNAPII) and productive tran-
scription elongation, to generate high levels of functional
messenger RNA (mRNA) (5,6). This recruitment of the
p-TEFb complex by bromodomain-containing protein 4
(Brd4) is triggered by a cascade of events initiated by
histone H3 Serine 10 (H3S10) phosphorylation and
leading to histone H4 acetylation (7). H3S10 phosphoryl-
ation is directed by IKKa at NF-kB-dependent genes
(8,9). p-TEFb activates elongation and RNA processing
by phosphorylating the C-terminal domain (CTD) of
RNAPII at Serine 2 (RNAPII S2p). This CTD is the
largest subunit of RNAPII (10); it comprises up to 52
tandemly repeated heptapeptides in mammals and serves
as a scaffold for a large range of nuclear factors (11).
Interestingly, the state of transcribing chromatin is intim-
ately linked to the phosphorylation state of the RNAPII
CTD (12,13). For example, the Set2 histone methyltrans-
ferase is recruited during transcription through CTD S5
and S2 phosphorylation and Set2 methylation of histone
H3 lysine 36 (H3K36me3) increases towards the 30-end of
genes where the S2/S5 double phosphorylation mark is the
highest (11,14). Interactions between the RNAPII CTD
and nuclear factors are not restricted to chromatin
modiﬁer enzymes because heterochromatin protein 1
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gamma (HP1g) also interacts with the RNAPII CTD
domain when it is phosphorylated on S2 or S5 and
recruits the facilitates chromatin transcription (FACT)
complex to RNAPII (15,16). HP1g is part of the HP1
family of proteins together with HP1a and HP1b in
vertebrates. HP1 proteins are commonly associated with
heterochromatin formation, as they are recruited to
methylated lysine 9 of histone H3. They can in turn
recruit methyltransferase to propagate silencing marks
along chromatin (17,18). In contrast to HP1a and HP1b,
HP1g is also located in euchromatin (19) where it can
be found phosphorylated at serine 93 (20). This post-
translational modiﬁcation abrogates the transcriptionally
repressive function of HP1g (21).
Because IKKa is recruited to transcribing regions (22),
we have studied the dynamics of IKKa recruitment to
NF-kB-dependent genes in macrophages after treatment
with lipopolysaccharide (LPS). We show that IKKa
phosphorylates not only histone H3S10 but also
H3.3S31 and HP1gS93. IKKa binds to RNAPII S2p,
and its association with chromatin, mainly at the 30-end
of genes seen in both cell lines and primary macrophages,
is transcription elongation dependent. Interestingly, we
show that IKKa does not bind to chromatin in absence
of HP1g, the latter being needed for phosphorylation of
histone H3.3S31. In vitro, HP1g directly interacts with
IKKa, accelerates IKKa-mediated phosphorylation of
H3.3S31 and inversely, decreases the rate of H3S10 phos-
phorylation. In addition, the presence of adenosine tri-
phosphate (ATP) favours the interaction between IKKa
and HP1g over the interaction between IKKa and
RNAPII S2p, suggesting a model in which both HP1g
and IKKa are recruited to the polymerase and then
loaded onto chromatin after IKKadependent phosphor-
ylation of HP1g. Finally, we show that IKKa co-localizes
at the 30-end of tumour necrosis factor (TNF) with its re-
pressor CUE-domain containing protein 2 (CUEDC2)
(23). These data indicate that IKKa chromatin modiﬁer
activity is playing a role in transcription elongation
beyond the p-TEFb recruitment step and is controlled
by HP1g.
MATERIALS AND METHODS
Cell culture
RAW264.7 cells were grown in Dulbecco’s modiﬁed
Eagle’s medium with 10% foetal calf serum and penicil-
lin–streptomycin. Mouse primary macrophages were
obtained from bone marrow by culturing in Iscove‘s
modiﬁed dulbecco‘s medium containing 10% foetal calf
serum and penicillin–streptomycin and 10% L cell condi-
tioned medium containing Macrophage colony-
stimulating factor (24) for 7 days. Where indicated, cells
were treated with 1 mg/ml LPS (Sigma) and 200 mM
5,6-dichloro-1-b-D-ribofuranosylbenzimidazole (DRB)
(Alexis). HP1g knockdown was achieved by transient
transfection of pMSCV-mir30-based shRNAs, designed
against mouse HP1g and ﬁreﬂy luciferase (25), using
Fugene HD (Promega). After transfection, RAW264.7
cells were incubated for 24 h and treated with LPS for
an additional hour.
Reverse transcription polymerase chain reaction
Total RNA was prepared and reverse transcription poly-
merase chain reaction (PCR) performed as described pre-
viously (26). Relative expression was calculated as a ratio
of speciﬁc transcript to glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) (for primer sequences see
Supplementary Table S1).
Chromatin immunoprecipitation assays and real-time
PCR analysis
Chromatin immunoprecipitation (ChIP) was performed as
described previously (22) using dynabeads protein G
(Invitrogen) with 2.4mg per 10 ml beads of anti-p65
(Santa Cruz sc-372X), anti-histone H3K9acS10p (Abcam
ab12181), anti-H3S10p (Millipore, 06-570), anti-H3
(Abcam ab1791), anti-H3.3S31p (Abcam ab92628),
anti-HP1g (Millipore 05-690), anti-HP1gS93p (Abcam
ab45270), anti-IKKa (Santa Cruz sc-7606X), anti-cdk9
(Santa Cruz sc-8338X), anti-Brd4 (Abcam ab46199),
anti-RNAPII S2p (Abcam ab5095), anti-RNAPII S5p
(Abcam ab5131), anti-RNAPII CTD (Abcam, ab817),
anti-RNAPII (Santa-Cruz sc-900X) and anti-CUEDC2
(Sigma PRS4839). Micrococcal Nuclease (MNase) experi-
ments have been conducted as described previously (27).
Depletion experiments were performed after a ﬁrst
immunoprecipitation (IP) with anti-RNAPII S2p with
chromatin prepared from 4 105 cells/IP, after which
the unbound fraction (supernatant collected after 2 h in-
cubation chromatin/beads/antibody) was divided into two
fractions to be incubated with anti-HP1g or anti-IKKa.
Re-ChIP was performed after a ﬁrst immunoprecipitation
with anti-RNAPII S2p with chromatin prepared from 107
cells/IP. After 2-h incubation, the beads were washed and
then incubated with 25 ml of 10mM dithiothreitol (DTT)
for 30min at RT. This eluted fraction was separated from
the beads diluted in 325 ml of IP buffer, and 100 ml was
incubated with anti-p65, anti-HP1g or anti-IKKa (22).
Quantitative Real-time PCR (qPCR) was performed as
described previously (28) with data normalized versus
input and then versus the average of control regions rep-
resenting enrichment base line (for primer sequences see
Supplementary Table S1).
Protein extraction
For whole cell lysate preparation, RAW264.7 cells were
washed in phosphate-buffered saline (PBS) and lysed
on ice for 20min in 300mM NaCl hypertonic cell lysis
buffer (HCLB-300) [20 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) pH7.5, 10mM
KCl, 0.5mM ethylenediaminetetraacetic acid (EDTA),
0.1% Triton X-100, 10% glycerol, 300mM NaCl] with
phosphatase and protease inhibitors [1 mM
b-glycerophosphate, 10mM NaF, 0.5mM Na3VO4,
1xproteinase inhibitors cocktail (Roche) and 0.5mM
phenylmethanesulfonylﬂuoride]. Lysates were centrifuged
and supernatant stored on ice for endogen-
ous co-immunoprecipitation (eCoIP). For cytosolic
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fractioning, cells were washed in PBS and lysed on ice in
HCLB-0 for 10min, spun at 200 g and the supernatant
stored on ice for CoIP. Nuclear pellets were then washed
in HCLB-0 and resuspended in HCLB-300 for 10min,
spun and supernatant retained on ice for eCoIP. For
DRB expression assays, proteins were collected from cell
lysed in radio immunoprecipitation assay (RIPA) buffer
[10 mM Tris–HCl pH 7.5, 1mM EDTA, 0.5mM ethylene
glycol tetraacetic acid, 140mM NaCl, 0.1% sodium
dodecyl sulphate (SDS), 1% Triton X100, 0.1% sodium
deoxycholate] on ice for 20min.
Endogenous co-immunoprecipitation
HCLB extracted cell lysates or nuclear extracts were all
equilibrated to 150mM NaCl. Lysates were pre-cleared
with 2.4 mg of either mouse or rabbit IgG isotype control
(Santa Cruz sc2025 and sc2027) immobilized on 15 ml
protein G dynabeads (Invitrogen) for 1 h at 4C.
Supernatants were then incubated with 2.4 mg primary
antibody immobilized on 15 ml protein G dynabeads
overnight at 4C. Antibodies used are described earlier
(see ‘Chromatin Immunoprecipitation assays and real-
time PCR analysis’ section) except for anti-IKKa (abcam
ab32041), mouse IgG2b (R+D systems MAB004).
Immobilized complexes were washed with HCLB buffer
(0, 150 and 300mM NaCl successively) and eluted in
elution buffer (100mM NaHCO3, 1% SDS) at room tem-
perature for 0.5 h. Samples were run on SDS-polyacryl-
amide gel electrophoresis (PAGE) and detected with
primary antibodies, see Supplementary Table S2.
In vitro CoIP
Recombinant proteins IKKa-GST (glutathione S-
transferase) (200 ng, Millipore 14-461), HP1g-GST
(Abnova H00011335-P01) and HP1a-His (Abcam
ab92015) were incubated in kinase buffer (KB) (1mg/ml
BSA, 25mM HEPES pH 7.9, 10mM MgCl2, 50mM
NaCl, 1mM DTT, 10mM KCl and 10% glycerol) for
1 h in the presence or absence of 200 mM ATP.
Immunoprecipitations were then carried out as described
for eCoIP.
Kinase assays
Recombinant proteins (100 ng) HP1g-GST or HP1a-HIS
and 1 mg of H3.3 (NEB M2507S), were added to KB. ATP
was added where indicated to 200 mM ﬁnal concentration.
Reactions were allowed to warm to 16C and started by
the addition of 50 ng IKKa-GST. Aliquots were removed
at indicated time points, mixed with SDS-LB and stored at
20C for western blot analysis against HP1gS93p,
H3S10p and H3.3S31p as described in Supplementary
Table S2. Antibodies were ﬁrst assayed to conﬁrm they
did not recognize unphosphorylated forms of the recom-
binant proteins.
Pull-down assays
Synthetic peptide corresponding to CTD-S2p (Abcam
ab1771) was biotinylated with Lightning Link
(InnovaBiosciences 7040030); 250 ng of biotinylated
peptide per reaction was immobilized on 10 ml of M280
streptavidin dynabeads (Invitrogen 112-09D) as per
manufacturer’s instructions. Recombinant proteins
(200 ng; IKKa-GST and HP1g-GST or HP1a-His) were
suspended in KB with biotinylated peptides in the
presence or absence of 200 mM ATP ﬁnal concentration
at room temperature for 30min. The immobilized
complexes were washed in PBS-T (0.05% Tween), twice
in KB and eluted in RIPA buffer. Samples were stored at
20C for analysis by western blot.
Peptide binding assay
Peptide (600 pmol) was incubated with 2 pmol of
IKK-GST recombinant protein in peptide-binding buffer
(PBB) (25mM Tris-HCl pH 8.0, 50mM NaCl, 1mM
DTT, 5% glycerol, 0.03% NP-40) for 30min before 5 ml
of magnetic glutathione beads (Pierce 88821) were added
for a further hour. Complexes were removed by magnet,
washed three times in PBB and eluted with 10mM gluta-
thione at room temperature. Supernatant was spotted
onto nitrocellulose and probed with anti-S5p or anti-S2p
(Supplementary Table S2). Densitometry of blots was
conducted using Quantity One on a GelDoc XR.
Measurements were taken from an area of set size.
Western blots
Western blots were carried out under denaturing condi-
tions with SDS-PAGE, and proteins were transferred to
polyvinylidene ﬂuoride membranes (for blocking condi-
tions and primary antibody concentrations see
Supplementary Table S2). HRP-conjugated secondary
antibodies were used at 1:20 000 (eBioscience).
RESULTS
IKKa accumulates at the 30-end of TNF after LPS
treatment in macrophages
LPS is a potent activator of NF-kB signalling pathways in
macrophages. On LPS stimulation, NF-kB binds to
speciﬁc deoxyribonucleic acid (DNA) sequences to stimu-
late high-level production of processed transcripts of its
target genes by recruitment of the Brd4/p-TEFb complex
(5). PIM1-dependent histone H3S10 phosphorylation is
necessary for Brd4/p-TEFb recruitment and activation
of transcription elongation of the FOSL1 gene (7). As
IKKa targets H3S10 at NF-kB-dependent genes (8,9),
we expected IKKa chromatin modiﬁer activity to be
associated with Brd4/p-TEFb recruitment. However, we
have previously shown that IKKa can also be recruited
to transcribing regions (22), suggesting an additional role
for this kinase in transcription elongation. To tackle
questions regarding the impact of IKKa on transcription
regulation, we focused on the murine TNF gene in the
RAW264.7 macrophage cell line as an experimental
model. Global transcriptional activation following
pro-inﬂammatory stimuli is heterogeneous, each gene re-
sponding with speciﬁc intensities and kinetics, making it
difﬁcult to perform global mechanistic studies with
multiple genes at the same time. However, the general
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mechanisms of transcription regulation are conserved
between genes and across species; therefore, observations
from our TNF model can serve as a paradigm for other
genes. TNF is a small gene that is rapidly induced and
highly transcribed in response to LPS treatment in macro-
phages (Figure 1A). Using this system, we performed
ChIP experiments to conﬁrm that NF-kB was binding to
the TNF promoter after LPS treatment in RAW264.7 cells
(Supplementary Figure S1A) and in primary macrophages
(Supplementary Figure S2A). We observed recruitment of
Brd4 mainly at the promoter of TNF, whereas Cdk9, the
catalytic subunit of p-TEFb, was present throughout the
coding region of this gene (Supplementary Figure S1B
and S1C). These data are in agreement with the described
model in which Brd4 recognizes and binds to acetylated
histone H3 and H4 (5,7,29) and then recruits p-TEFb,
Figure 1. The response of the TNF locus to LPS treatment. (A) Time course of TNF mRNA levels in RAW264.7 cells in response to LPS treatment.
Results are expressed relative to GAPDH expression. Error bars represent standard deviation (SD) from three independent experiments. (B) Positions
and names of the amplicons designed within the TNF locus for the ChIP experiments. ChIP performed with RAW264.7 cells treated with LPS for
the indicated time points in minutes: (C) anti-H3K9acS10p, (D) anti-IKKa, (E) anti-HP1g, (F) anti-H3.3S31p and (G) anti-HP1gS93p. Horizontal
axis indicates primers used for the real-time PCR (distance in kb from the transcription start site or CCCTC-binding factor CTCF-binding site at the
vicinity of the indicated gene, see B). Data are normalized versus input and then versus an average of background control regions. Error bars
represent SD from three independent qPCR replicates. (C–G) Data are representative of at least three independent experiments.
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which in turn phosphorylates RNAPII S2 to drive pro-
ductive transcription elongation and mRNA processing
(5,7).
Next, we performed additional ChIP experiments to
look for H3S10p enrichment and IKKa recruitment at
the TNF locus after LPS treatment. Because many genes
undergo global changes in chromatin structure on activa-
tion, we ﬁrst analysed the nucleosome landscape of TNF
using anti-histone H3 antibody and observed a rapid
decrease in nucleosome content extending beyond TNF
(Supplementary Figure S1D), as described previously for
heat-shock genes (30). We also detected a rapid and tran-
sient increase in the level of histone H3 modiﬁed by both
lysine 9 acetylation and H3 serine 10 phophorylation, with
a peak at 15min localized 100 bp downstream of the tran-
scription start site at the +1 nucleosome (Figure 1C) in
parallel with recruitment of Brd4 and p-TEFb in this
region. The same proﬁle was detected by ChIP with
antibodies against either the double mark H3K9acS10p
or the single mark H3S10p (Supplementary Figure S1E).
However, H3S10 phosphorylation appeared to be an early
event in TNF transcriptional activation and was not main-
tained throughout the time course of TNF transcription,
in contrast to both Brd4 and Cdk9 recruitments. These
data support the view that H3S10p initiates Brd4 recruit-
ment to the promoter but that it is not necessary to
maintain this modiﬁcation after the onset of transcription.
When we focused our analysis on the 50-end of the
gene, we also detected the highest IKKa enrichment at
the +1 nucleosome correlated with total RNAPII
(Supplementary Figure S3A and S3B) suggesting recruit-
ment of IKKa to the region of RNA polymerase pausing.
However, a wider view of IKKa distribution along TNF
revealed a much more substantial accumulation of IKKa
downstream of the transcription end site (TES) of the gene
in both the RAW264.7 cell line and primary macrophages
(Figure 1D and Supplementary Figure S2B). This 30-end
accumulation of IKKa was not restricted to TNF, as other
LPS inducible and NF-kB-dependent genes presented a
similar distribution of this protein around coding
regions (Ccl3 and Il1b, Supplementary Figures S3C,
S3D, S4A and S4E). A DNase I hypersensitive site
(DHS) has previously been detected downstream of the
human TNFa transcription end site (31) (Figure 1B).
This DHS is occupied by NF-kB and interferon regulatory
factor 5 in macrophages and dendritic cells after LPS
treatment (32,33). However, the possibility that the re-
cruitment of IKKa at the 30-end of TNF occurs solely
by transcription factors at this DHS is very unlikely,
because IKKa enrichment (25 times higher than
observed at the promoter) covers a large region extending
from the TES to at least 600 bp downstream from this
DHS. In addition, the +2.7 kb amplicon, in which the
mouse conserved sequences for the two described
NF-kB-binding sites are included, did not reveal signiﬁ-
cant binding of NF-kB in this region after LPS treatment
(Supplementary Figures S1A and S2A). Besides the role of
IKKa as the kinase phosphorylating histone H3S10 at
NF-kB-dependent genes, our data argue for additional
roles of this enzyme in transcription elongation down-
stream p-TEFb recruitment.
LPS treatment induces accumulation of HP1c and
H3.3S31p in the coding region of TNF
To unravel the new roles of IKKa in transcription, we ﬁrst
looked for potential substrates catalysed by this enzyme.
HP1g and the histone variant H3.3 are speciﬁcally
enriched at transcriptionally active genes (15,34) with
H3.3 enrichment observed at the TES of transcribed se-
quences (35). Because HP1gS93p is a marker of transcrip-
tion elongation (20) and H3.3S31 represents the only
amino acid difference between the N-terminal tails of the
histone variants H3.1 and H3.3, both serines represent
attractive potential chromatin targets for IKKa. Indeed,
our ChIP experiments revealed that both HP1g and
H3.3S31p were enriched within the coding region of
TNF and Ccl3 genes after LPS treatment (Figure 1E
and F, Supplementary Figures S2C, S4C and S4D), and
a peak of HP1gS93p was detected at the 30-end of TNF
in a region where IKKa enrichment was the highest
(Figure 1G). In addition, In vitro kinase assays using re-
combinant IKKa incubated with HP1g and histone H3.3
showed that IKKa phosphorylates not only H3.3S10 but
also H3.3S31 and HP1gS93 (Figure 2A and B). In these
assays, the presence of HP1g altered the IKKa kinase spe-
ciﬁcity, whereas HP1a did not. The presence of HP1g
accelerated the rate of H3.3S31 phosphorylation,
whereas the rate and level of H3S10 phosphorylation
was decreased (Figure 2B). In addition, eCoIP experi-
ments done with anti-HP1g antibody and nuclear
extracts from LPS-treated cells (untreated cells showing
no detectable level of IKKa in the nucleus) or with recom-
binant proteins and anti-HP1g or anti-IKKa antibodies
showed interaction between IKKa and HP1g but not
between IKKa and HP1a (Figure 2C–E). The reciprocal
experiment with anti-IKKa antibody did not
co-precipitate HP1g when incubated with nuclear
extracts. We hypothesized that the epitope of this mono-
clonal antibody may be masked in vivo. In addition, using
recombinant proteins, we observed that the interaction
between IKKa and HP1g was direct and stronger in the
presence of ATP (Figure 2D). This ATP-dependent direct
interaction between IKKa and HP1g would justify the
observed co-localization of IKKa and HP1gS93p on chro-
matin template. In summary, we identiﬁed two new targets
for IKKa during transcription and lifted the veil on what
appears to be a complex interdependency between HP1g
and IKKa.
Accumulation of both IKKa and HP1c to TNF is
transcription elongation dependent
IKKa distribution along TNF coding region is correlated
with RNAPII S2p enrichment (Supplementary Figures
S1F and S2D) suggesting that IKKa may travel with the
elongating RNA polymerase. To test the link between the
progression of the elongating form of RNAPII through
chromatin and the accumulation of IKKa and also HP1g
and H3.3S31p to TNF after LPS treatment, we treated
RAW264.7 cells with 5,6-dichloro-1-b-D-ribofuranosyl-
benzimidazole (DRB). DRB is a selective inhibitor of
transcription elongation by inhibition of Cdk9 kinase
activity (36). We treated RAW264.7 cells with LPS for
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30min in the presence or absence of DRB, or alterna-
tively, we added DRB 30min after the addition of LPS
for an additional 30min. We ﬁrst conﬁrmed that DRB
treatment was blocking TNF expression and RNAPII
transcription elongation (Supplementary Figure S5A and
S5B) and checked whether this treatment was affecting
global levels of IKKa or HP1g proteins or H3.3S31 phos-
phorylation (Figure 3A). In this experiment, we observed
a severe reduction of total H3.3S31p, implying that this
post-translational modiﬁcation is a transient mark, which
is directly dependent on transcription elongation
(Figure 3A). We did previously establish that DRB was
preventing LPS-dependent recruitment of IKKa to chro-
matin (22). In agreement with this observation, DRB
treatment prevented not only recruitment but also main-
tenance of IKKa and HP1g proteins to the TNF locus
(Figure 3B and C). In contrast, DRB treatment increased
total RNAPII enrichment and NF-kB binding to the TNF
promoter, suggesting that initiation complexes remained
bound to the chromatin and indicating that DRB did
not lead to a non-speciﬁc loss of chromatin-associated
proteins from the TNF locus (Supplementary
Figure S5C and S5D). Next we performed a ChIP experi-
ment with an anti-RNAPII S2p antibody, eluted the
complexes and repeated the immunoprecipitation
(re-ChIP), with antibodies against IKKa, HP1g or p65
(NF-kB). NF-kB was only detected together with
RNAPII S2p in the promoter region (Figure 4A). In
contrast, IKKa and HP1g associated with RNAPII S2p
were both equally spread along the gene (Figure 4B and
C). Such co-puriﬁcation and the fact that DRB prevents,
as described previously (22), and even reverses accumula-
tion of both IKKa and HP1g to the TNF locus, without
affecting NF-kB binding, support a model, in which both
HP1g and IKKa interact with the elongating polymerase
during transcription elongation.
IKKa can bind to phosphorylated RNAPII CTD
in the absence of HP1c
FACT recruitment to RNAPII has been shown to be de-
pendent of HP1c in drosophila (16). Because both HP1g
and IKKa detection to TNF was transcription elongation
dependent, we tested whether IKKa was recruited by
HP1g to the RNA polymerase. For this, we ﬁrst per-
formed eCoIP using whole cell extracts and showed an
interaction between both IKKa and HP1g and
phosphorylated RNAPII CTD, whereas these proteins
were inefﬁcient at co-immunoprecipitating the
unphosphorylated RNAPII CTD (Figure 5A and Sup-
plementary Figure S6). Then GST pull-down experiments
performed with recombinant IKKa and both CTD S2p
and CTD S5p peptides revealed that IKKa was binding
to phosphorylated RNAPII CTD in absence of HP1g
(Figure 5B and D). In addition, when both peptides
were incubated with IKKa, the amount of bound CTD
S5p was reduced compared with incubation of IKKa with
only CTD S5p (compare bound fractions bottom of
Figure 5B; lanes 4 and 5). This was not the case for the
same comparison with only CTD S2p (compare bound
fractions top of Figure 5B; lanes 3 and 5). This observa-
tion was conﬁrmed by densitometric quantiﬁcation
Figure 2. IKKa interacts with HP1g and histone H3.3. (A) IKKa kinase assay with recombinant HP1g. Western blot has been performed with
anti-IKKa, anti-HP1gS93p and anti-HP1g. (B) IKKa kinase assay with recombinant IKKa and histone H3.3 in presence or absence of recombinant
HP1g (top) or HP1a (bottom). Western blot has been performed with anti-IKKa, anti-H3S10p, anti-H3.3S31p, anti-HP1g and anti-HP1a antibodies.
(C) eCoIP experiments with nuclear extract from RAW264.7 cells treated with LPS for 1 h. Antibodies used for immunoprecipitation are named at
the top of the ﬁgure and antibodies used for western blot named on the left. Input was 5% of material used for CoIP. (D) In vitro CoIP experiment
performed with recombinant HP1g–GST or IKKa–GST incubated with or without ATP and immunoprecipitated with anti-HP1g or anti-IKKa
antibodies. Western blot performed with anti-HP1g or anti-IKKa antibodies. (E) In vitro CoIP experiment performed with recombinant HP1a-HIS
incubated with recombinant HP1g–GST or IKKa–GST and immunoprecipitated with anti-HP1a or anti-IKKa antibodies. Western blot performed
with anti-HP1a antibody.
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(Figure 5C). Together these results show that IKKa has a
stronger afﬁnity for CTD S2p than CTD S5p. Finally,
additional pull-down experiments with recombinant pro-
teins incubated with a biotinylated peptide corresponding
to the CTD S2p showed that the interaction between
IKKa and the CTD S2p peptide was weaker in the
presence of both HP1g and ATP, whereas the interaction
between HP1g and this peptide was unaffected by the
presence of ATP (Figure 5D, compare lane 8 with
lane 9). In the same experiment, we also observed that
HP1g interaction with the CTD S2p peptide was
strongly reduced in the presence of IKKa (Figure 5D,
compare lane 4 with lane 8). Taken together, we high-
lighted a complex and dynamic interaction between
phosphorylated RNAPII, IKKa and HP1g.
HP1c controls IKKa recruitment to chromatin
As HP1g can alter the dynamics of histone H3.3 phos-
phorylation by IKKa and because HP1g and H3.3S31p
proﬁles at TNF overlap, we were aiming to further inves-
tigate the role of HP1g in IKKa chromatin modifying
activity. Manipulation of IKKa protein level or kinase
activity affects NF-kB-dependent gene expression before
the p-TEFb recruitment step (4,37–39) making it difﬁcult
to properly assess events happening downstream of tran-
scription initiation. Therefore, to further study the rela-
tionship between HP1g and IKKa kinase activity during
transcription elongation, we performed HP1g knockdown
and assessed MNase accessibility, TNF mRNA expression
and localization of IKKa and RNAPII S2p at this locus
(Figure 6). After up to 80% and 50% reduction of HP1g
mRNA and protein levels, respectively (Figure 6A and B),
we did not observe any effect on NF-kB recruitment to the
promoter (Supplementary Figure S7A) indicating that
HP1g knockdown does not interfere with activation of
the NF-kB pathway on LPS activation. However, we
detected increased TNF and Ccl3 expression (Figure 6A
and Supplementary ﬁgure S7B) correlated with an increase
in RNAPII S2p recruitment within TNF coding region
(Figure 6C). These changes were accompanied by an
increased chromatin accessibility of TNF as shown by
the reduced qPCR signal obtained after ampliﬁcation
of genomic DNA prepared from chromatin treated
with MNase, whereas total histone H3 was unaffected
(Figure 6D and Supplementary Figure S7E). Altogether
these data are in agreement with a repressive role of HP1g
in transcription. Finally, we also observed a reduction of
H3.3S31 phosphorylation suggesting that HP1g controls
H3.3S31 phosphorylation (Figure 6E). However, in these
experiments, we did not see any signiﬁcant effect of HP1g
knockdown on the recruitment of HP1g and IKKa or the
enrichment of HP1gS93p at this locus (Supplementary
Figure S7C, S7D and S7F). Because our previous experi-
ments showed an association between HP1g, IKKa and
elongating RNA polymerase and because HP1g was only
partially knocked down, we hypothesized that the
decreased association of HP1g with chromatin at this
locus after knock down was masked by an increased
amount of ‘travelling’ HP1g in correlation with the
increased level of elongating polymerase detected in the
TNF locus. Therefore, to distinguish between ‘travelling’
and chromatin-associated HP1g and IKKa, we performed
ChIP on RNAPII S2p ‘depleted’ chromatin. As a proof
of principle, the unbound fraction of a ﬁrst RNAPII
Figure 3. Transcription elongation-dependent accumulation of IKKa,
HP1g and H3.3S31 phosphorylation at the TNF locus. (A)
Quantiﬁcation of total IKKa, HP1g, H3.3S31p, H3.3 and b-actin
protein levels by western blot with total cell extract, after RAW264.7
cells incubation with LPS+DRB. RAW264.7 cells treated with LPS in
presence or absence of DRB for 30min LPS (30), 30min LPS+DRB
(30+DRB), 60min LPS (60) or 30min LPS following by 30min with
DRB (60+DRB). ChIP performed with (B) anti-IKKa and (C)
anti-HP1g. Horizontal axis indicates primers used for the real-time
PCR. Data are normalized versus input and then versus an average
of control regions. Data are representative of at least three independent
experiments. Error bars represent standard deviation (SD) from three
independent qPCR replicates.
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S2p ChIP (Figure 7A) was used for a second round of
ChIP with anti-RNAPII S2p or anti-HP1g antibodies
(Figure 7B). This control experiment showed that
anti-RNAPII S2p antibody precipitated 50 times less
DNA from this ‘unbound’ fraction compared with the
ﬁrst round of ChIP, whereas HP1g ChIP was not signiﬁ-
cantly affected, conﬁrming a speciﬁc and efﬁcient deple-
tion of the elongating polymerase associated with
chromatin from the template (Figure 7A and B). Then,
we performed a second round ChIP with RNAPII
S2p-depleted chromatin and antibodies against NF-kB,
HP1g and IKKa. As expected, we did not see any differ-
ence in NF-kB recruitment after HP1g knockdown
but saw a signiﬁcant reduction of both HP1g and IKKa
accumulation at the TNF locus (Supplementary Figures
S8A, S7C and S7D). In this experiment, the ratio of
IKKa versus HP1g enrichment was conserved after
HP1g knockdown indicating a strict correlation between
the losses of chromatin-bound HP1g and chromatin-
bound IKKa (Supplementary Figure S8B). Taken
together, these results show that IKKa recruitment
to chromatin and histone H3.3S31 phosphorylation
are HP1g dependent. It also conﬁrms that chromatin
bound IKKa does exist in a form dissociated from
RNAPII.
CUEDC2 co-localizes with IKKa at the 30-end of TNF
and Ccl3
We found a correlation between HP1g and H3.3S31p ac-
cumulation within the coding region of TNF. However, if
IKKa mediates H3.3S31 phosphorylation, then the
presence of H3.3S31p should peak where RNAPII S2p
independent IKKa enrichment is at the maximum, i.e. at
the 30-end of the TNF gene (Figure 1D and Supplementary
Figure S2B). IKKa activity is regulated by NIK and
CUEDC2 (23,40). For this reason, a non-strict correlation
between chromatin-associated IKKa and H3.3S31p could
be explained by modulations of the IKKa kinase activity
during the transcription elongation process. Looking for
interactions between IKKa and the CUEDC2/PP1
complex by eCoIP, we showed that IKKa was indeed
interacting with this complex in the nucleus and in the
cytoplasm (Figure 8A). In addition, ChIP experiments
revealed an accumulation of CUEDC2 in the 30-end of
the gene together with IKKa, suggesting that at the 30-
end of TNF, IKKa was inactivated (Figure 8B). We
observed the same accumulation at the 30-end of Ccl3
(Supplementary Figure S4B). These results suggest a
close control of IKKa activity during transcription
elongation.
Figure 4. Re-ChIP. Re-ChIP performed in RAW264.7 cells treated with LPS for 1 h, with anti-RNAPII S2p antibody and then with (A) anti-IKKa,
(B) anti-HP1g and (C) anti-p65 antibodies. Horizontal axis indicates primers used for the real-time PCR. Data are normalized versus IP performed
with anti-RNAPII S2p antibody. Data are representative of two independent experiments. Error bars represent standard deviation (SD) from three
independent qPCR replicates.
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DISCUSSION
Despite extensive studies, the role of IKKa in NF-kB
signalling pathways is still controversial, mainly due to
its contribution at different stages of the signalling
cascades, making functional studies difﬁcult. IKKb
appears to be the main kinase controlling NF-kB release
into the nucleus (8,9). However, IKKa increases NF-kB-
mediated transcription by removing repressor complexes
from targeted promoters and by facilitating p65 binding to
DNA for a selected number of NF-kB-dependent genes
(37,39). Conversely, IKKa also accelerates both the
turnover of the NF-kB subunits and their removal from
pro-inﬂammatory gene promoters, limiting macrophage
activation and inﬂammation (38). Downstream of
NF-kB recruitment to DNA, this kinase is also known
to phosphorylate H3S10, a histone mark triggering
Brd4/p-TEFb recruitment (5,7–9). Herein, we reveal
new chromatin targets for IKKa during transcription
elongation of NF-kB-dependent genes. We show that
IKKa plays a role in transcription even further down-
stream of the initiation of productive transcription by
phosphorylating not only H3S10 but also H3.3S31 and
HP1gS93. Absence of H3S10p at the promoter of TNF
in response to LPS was previously reported (41). In our
hand, H3S10p stays at a relatively low level at the
promoter but peaks at the+1 nucleosome of TNF, early
after LPS stimulation, in correlation with Brd4/p-TEFb
recruitment. H3.3S31p then progressively replaces
H3S10p in the gene body in parallel with accumulation
of HP1g. Both events correlate with enrichment of
IKKa at the 30-end of genes, downstream of the TES in
a region where HP1gS93 is phosphorylated and RNAPII
S2p high. In addition, even if NF-kB recruits IKKa to
NF-kB-dependent genes (8,9), the interaction between
NF-kB and IKKa on DNA appears to be unstable. This
hit-and-run type of interaction seems to be independent of
IKKa loading onto the RNA polymerase, as DRB treat-
ment does not induce any accumulation of this enzyme at
the promoter.
Our work reveals a central role for HP1g in controlling
IKKa chromatin-modifying activity and a role for IKKa
in controlling HP1g (see proposed model in Figure 8C).
We show that IKKa directly binds to HP1g Both proteins
interact with phosphorylated RNAPII CTD and their ac-
cumulation, and maintenance at the TNF locus is strictly
dependent on RNAPII S2p. This interaction between
HP1g and phosphorylated RNAPII CTD is in agreement
with previous publications (15,16). Moreover, we
Figure 5. IKKa binds directly to RNAPII CTD S2p. (A) eCoIP performed with whole cell extract from RAW264.7 cells treated with LPS for 1 h.
Antibodies used for immunoprecipitation are named at the top of the ﬁgure and antibodies used for western blot named on the left. Input was 5% of
material used for CoIP. (B) In vitro pulldown followed by dot blot assay. GST-IKKa (2 pmol) was incubated in the absence of peptide (lane 2) or in
the presence of 600 pmol CTD-S2p (lane 3) or CTD-S5p (lane 4) peptides or an equimolar mix of the two (lane 5). A GST-control peptide, not
interacting with RNAPII, was incubated with the same equimolar mix of the two peptides (lane 1). Pulldown was performed with anti-GST beads.
Unbound and bound factions were transferred onto the membrane. Antibodies used for dot blot are named on the left. (C) The competition between
peptides for binding to IKKa was quantiﬁed using densitometry. Data are expressed as a ratio (bound/unbound)S2p+S5p/(bound/unbound)S2p or
S5p. Error bars represent standard deviation (SD) of two independent experiments. (D) In vitro pull-down experiment performed with a biotinylated
peptide corresponding to the CTD S2p incubated with recombinant HP1a, HP1g and IKKa proteins in the presence or absence of ATP.
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identiﬁed two populations of HP1g and IKKa proteins
during transcription: one travelling with the polymerase
and the other associated with chromatin. HP1g afﬁnity
for RNAPII S2p decreases in the presence of IKKa, and
the presence of ATP favours IKKa interaction with HP1g
over RNAPII S2p, suggesting a mechanism in which both
proteins are recruited to the RNAPII CTD and loaded
onto chromatin after HP1g phosphorylation driven by
IKKa. The correlation between IKKa and HP1gS93p en-
richment at the 30-end of TNF and the fact that no change
in Hp1gS93p enrichment level is observed after HP1g
knockdown, establishing that travelling HP1gS93p com-
pensates for the loss of chromatin-associated HP1gS93p,
argue in support of such a mechanism. In addition, our
ChIP experiments performed with chromatin ‘depleted’
for elongating polymerase show that HP1g allows
association of IKKa with chromatin and subsequent
phosphorylation of H3.3S31. Similarly in Drosophila,
the expression of heat-shock genes is dependent on
recruitment of FACT to heat-shock loci by HP1c
(16). However, in contrast with what we observe in our
system, FACT cannot bind to the active forms of RNAPII
in the absence of HP1c.
Transcription termination occurs after dismantling of
the elongation complex from DNA by the polyadenylation
cleavage factor Pcf11 (42,43), and therefore, RNA poly-
merase does not pass through nucleosomes downstream
of the TES, providing clues to determining the order of
Figure 6. HP1g knockdown increases expression of TNF and abolishes H3.3S31 phosphorylation. (A) HP1g, TNF and IKKa mRNA levels in
RAW264.7 cells after HP1g knockdown using three shRNAs against HP1g (sh-1, -2 and -3) or ﬁreﬂy luciferase (sh-c) after 1 h LPS treatment.
Results are expressed relative to GAPDH expression. Error bars represent standard deviation (SD) from three independent experiments.
(B) Quantiﬁcation of total HP1g and b-actin protein levels by western blot with total cell extract, after HP1g knockdown (sh-1) in RAW264.7
cells. (C,E) ChIP performed, after HP1g knockdown in RAW264.7 cells treated with LPS for 1 h, with (C) anti-RNAPII S2p and (E) anti-H3.3S31p
antibodies. Horizontal axis indicates primers used for the real-time PCR. Data are normalized versus input or (E) total histone H3 and then versus
an average of background control regions. (D) qPCR quantiﬁcation of MNase-treated chromatin. (C–E) Data are representative of at least three
independent experiments. Error bars represent SD from three independent qPCR replicates.
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events which may occur when RNAPII reaches a nucleo-
some (Figure 8C). First, the IKKa/HP1gS93p complex
could be loaded from the phosphorylated RNAPII CTD
onto the chromatin. In the body of the actively transcribing
TNF, IKKa enrichment is low compared with the 30-end,
HP1gS93 is unphosphorylated and H3.3S31 phospho-
rylated. Again, the IKKa enrichment proﬁle at TNF
suggests a hit-and-run mechanism for this enzyme in the
body of the gene. Consequently, we concluded that the
passage of the polymerase through the nucleosome would
be associated with H3.3S31 phosphorylation by IKKa
(hit), IKKa eviction from the chromatin (run) and HP1g
dephosphorylation. Interestingly, at the 30-end of TNF,
we found a signiﬁcant amount of chromatin-bound
IKKa not associated with RNAPII S2p. In this region,
IKKa and its repressor CUEDC2 co-localize, suggesting
that, in parallel with transcription termination, CUEDC2
prevents H3.3S31 phosphorylation and IKKa hit-and-run
activity.
The exact function of the described sequential post-
translational modiﬁcations is still not understood. HP1g
is commonly associated with transcribing chromatin
(15,16,19,44), where it is found phosphorylated, a
post-translational modiﬁcation impairing HP1g-repressive
activity (20,21). We have determined that HP1g knock-
down correlates with a decrease in chromatin-associated
HP1g and a higher rate of TNF transcription in agreement
with a repressive role for this protein during transcription
elongation. However, we also revealed a correlation
between the elongating polymerase present at TNF locus
andHP1g associated with this polymerase. This correlation
suggests a dual role for HP1g during transcription, a
positive role by recruiting FACT to chromatin (16) and a
repressive role when bound to chromatin after the passage
of the polymerase through nucleosomes. By targeting
HP1g, IKKa would control HP1g dual activity.
When recruited to chromatin, IKKa may also play a
role to facilitate or repress the elongating polymerase to
read through nucleosomes during transcription elong-
ation. In this context, the function of H3.3S31p is
unclear. Because H3.3S31 is not phosphorylated down-
stream of TNF where IKKa and CUEDC2 co-localize,
we hypothesize that H3.3S31p could facilitate transcrip-
tion elongation. This histone mark is evidently
co-enriched in coding regions with non-phosphorylated
HP1g, the ‘repressive’ form of HP1g, whereas HP1gS93p
is restricted to the 30-end. However, transcription elong-
ation being a very dynamic process, it may just indicate
Figure 7. HP1g knockdown reduces chromatin-associated IKKa. HP1g knockdown in RAW264.7 cells treated with LPS for 1 h. (A) ChIP per-
formed with anti-RNAPII S2p and anti-HP1g normalized versus input only. The unbound fraction of a ﬁrst anti-RNAPII S2p ChIP was used as a
template for a second ChIP, (B) with anti-RNAPII S2p and anti-HP1g normalized versus the unbound fraction only, (C) with anti-HP1g and (D)
anti-IKKa. (A–D) Horizontal axis indicates primers used for the real-time PCR. (C,D) Data are normalized versus the unbound fraction (Unb) and
then versus an average of control regions. Data are representative of at least ﬁve independent experiments. Error bars represent± standard deviation
(SD) from three independent qPCR replicates.
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Figure 8. CUEDC2 accumulates at the 30-end of TNF gene. (A) eCoIP experiment with nuclear and cytoplasmic extracts from RAW264.7 cells
treated with LPS for 1 h and precipitated with anti-IKKa antibody followed by western blot with anti-HPRT, anti-PP1 and anti-CUEDC2
antibodies. (B) ChIP with RAW264.7 cells treated with LPS performed with anti-CUEDC2 antibody. Horizontal axis indicates primers used for
the real-time PCR. Data are normalized versus input and then versus an average of control regions. Data are representatives of at least three
independent experiments. Error bars represent± standard deviation (SD) from three independent qPCR replicates. (C) Suggested model of IKKa
cycling activity during transcription elongation. (Step 1) Both IKKa and HP1g bind to phosphorylated RNAPII CTD. IKKa phosphorylates
HP1gS93. (Step 2) The complex IKKa/HP1gS93p is transferred to chromatin. (Step 3) The presence of HP1g favours H3.3S31 phosphorylation
by IKKa. (Step 4) After the passage of the RNA polymerase, H3.3S31 is phosphorylated, unphosphorylated HP1gS93 is high and IKKa low.
(transcription termination) CUEDC2 co-localizes with the IKKa/HP1gS93p complex on chromatin, whereas H3.3S31 is not phosphorylated.
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that H3.3S31p is dephosphorylated a step later than
HP1gS93p. In addition, an increased rate of TNF tran-
scription in absence of both H3.3S31p and HP1g may
mean that H3.3S31p speciﬁcally antagonizes HP1g-repres-
sive function and is therefore dispensable in absence of the
latter. Histone H3K36 methylation is another histone
mark associated with transcription elongation (45).
Similar to HP1g, H3K36me3 is found within coding
regions of actively transcribing genes where it negatively
inﬂuences gene expression including the repression of
cryptic promoters (46). H3K36me3 is speciﬁcally
enriched within exons (47,48) where it may slow the rate
of RNAPII elongation to increase inclusion of alterna-
tively spliced exons (49), a role also described for HP1g
(50). H3.3S31p may have a positive action on transcrip-
tion by antagonizing H3K36me3 by different mechanisms.
Similar to H3S10, H3.3S31p may trigger histone acetyl
transferase recruitment (7) to antagonize H3K36me3-
mediated recruitment of histone deacetylase (51) or it
may control H3P30 and H3P38 isomerizations, post-
translational modiﬁcations preventing H3K36me3 (52).
HP1g and H3.3 co-enrichment can be restricted to pro-
moters as recently described for HSP70 gene after heat
shock (53), suggesting distinct mechanisms preventing or
allowing spreading of HP1g/H3.3 along coding regions.
Differences in chromatin structure may account directly
or indirectly for such repartition along genes. Although
further investigations will be necessary to decipher these
mechanisms, we did not establish a link between HP1g/
H3.3 recruitment to coding regions and nucleosome
density because the nucleosome landscape across the
entire coding region of HSP70 after heat shock (30) is
similar to the one we described for TNF on LPS induction.
In conclusion, we have unravelled new functional inter-
actions for the chromatin modifying enzyme IKKa and
HP1g during transcription elongation of NF-kB-depend-
ent genes. Because NF-kB is a complex family of tran-
scription factor activated by multiple stimuli, it will be
important to determine whether IKKa is selectively re-
cruited to a subclass of NF-kB-dependent genes or
whether this enzyme is widely recruited by the different
subunits of this family including non-canonical subunits
such as p52 or RelB, the latter regulating transcription
elongation (54). In addition, because, neither incorp-
oration of histone H3.3 into chromatin nor Hp1gS93
phosphorylation is restricted to the transcription of
NF-kB-dependent genes, we expect the mechanism we
are describing herein to be more universal with other
kinases fulﬁlling the role of IKKa for other genes.
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